Integrated Wealth Concepts’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.61M | Sell |
31,416
-3,489
| -10% | -$289K | 0.03% | 536 |
|
2025
Q1 | $2.83M | Buy |
34,905
+7,780
| +29% | +$631K | 0.03% | 487 |
|
2024
Q4 | $2.44M | Buy |
27,125
+5,701
| +27% | +$513K | 0.03% | 498 |
|
2024
Q3 | $2.12M | Sell |
21,424
-11,002
| -34% | -$1.09M | 0.03% | 532 |
|
2024
Q2 | $3.01M | Buy |
32,426
+9,230
| +40% | +$856K | 0.04% | 385 |
|
2024
Q1 | $2.2M | Buy |
23,196
+1,698
| +8% | +$161K | 0.03% | 491 |
|
2023
Q4 | $1.92M | Sell |
21,498
-2,158
| -9% | -$193K | 0.03% | 500 |
|
2023
Q3 | $1.73M | Buy |
23,656
+2,021
| +9% | +$148K | 0.03% | 499 |
|
2023
Q2 | $1.8M | Buy |
21,635
+155
| +0.7% | +$12.9K | 0.03% | 502 |
|
2023
Q1 | $1.64M | Buy |
21,480
+791
| +4% | +$60.3K | 0.03% | 473 |
|
2022
Q4 | $1.72M | Buy |
20,689
+4,122
| +25% | +$342K | 0.05% | 349 |
|
2022
Q3 | $1.31M | Sell |
16,567
-1,370
| -8% | -$109K | 0.04% | 364 |
|
2022
Q2 | $1.33M | Buy |
17,937
+130
| +0.7% | +$9.65K | 0.04% | 371 |
|
2022
Q1 | $1.6M | Buy |
17,807
+1,766
| +11% | +$159K | 0.05% | 299 |
|
2021
Q4 | $1.8M | Buy |
16,041
+2,171
| +16% | +$243K | 0.05% | 284 |
|
2021
Q3 | $1.74M | Buy |
13,870
+2,434
| +21% | +$306K | 0.06% | 267 |
|
2021
Q2 | $1.55M | Buy |
11,436
+3,231
| +39% | +$437K | 0.05% | 262 |
|
2021
Q1 | $1.11M | Sell |
8,205
-602
| -7% | -$81.7K | 0.05% | 274 |
|
2020
Q4 | $1.24M | Sell |
8,807
-48
| -0.5% | -$6.76K | 0.06% | 214 |
|
2020
Q3 | $987K | Buy |
8,855
+545
| +7% | +$60.7K | 0.06% | 220 |
|
2020
Q2 | $930K | Buy |
8,310
+1,392
| +20% | +$156K | 0.07% | 190 |
|
2020
Q1 | $536K | Buy |
+6,918
| New | +$536K | 0.05% | 218 |
|